Skip to Content

Clinical Trials Search Results

Showing 1-3 of 3

Sorted By:

  • CALGB 50904

    A Randomized Phase II Trial of Ofatumumab and Bendamustine vs. Ofatumumab, Bortezomib, and Bendamustine in Patients with Untreated Follicular Lymphoma

  • ECOG-ACRIN E1412

    Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs RCHOP (Rituximab Cyclophosphamide, Doxorubicin, Cell Lymphoma

  • OMB 113676

    Phase III Randomized, Open Label Study of Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy

Showing trials 1-3 of 3

Also in this Section